Pradžia › Miastenija gravis › Ilinoisas
Miastenija gravis klinikiniai tyrimai Ilinoisas
12 tyrimai dėl Miastenija gravis ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10105, O'Fallon
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- HSHS St. Elizabeth's Hospital, O'Fallon
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07217587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- HSHS Medical Group - St. Elizabeth's Hospital, O'Fallon
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT07501702RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06359041Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Chicago
- Aurinia Investigational Site, O'Fallon
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-08-03 · NCT07596901Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-07-30 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Hospital Sisters Health System Medical, O'Fallon
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-18 · NCT06456580A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Chicago
- Research Site, Schaumburg
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-09 · NCT07221838Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
- Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital, Chicago
Renkami dalyviai2/3 fazė
Amžius nuo 2 iki 18 · Visoms lytims · Atnaujinta 2026-02-18 · NCT04833894A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Prairie Education and Research Cooperative and HSHS Medical Group, O'Fallon
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-17 · NCT06298565Vitaccess Real MG Registry
- HSHS St. Elizabeth's Hospital, O'Fallon
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-07-29 · NCT06064461Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
- ZS Associates, Evanston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-03-10 · NCT06866483Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.